- Home
- BLIV vs ACRV Comparison
BLIV vs ACRV Comparison
Compare BLIV & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIV
- ACRV
- Stock Information
- Founded
- BLIV 2014
- ACRV 2018
- Country
- BLIV Singapore
- ACRV United States
- Employees
- BLIV N/A
- ACRV N/A
- Industry
- BLIV
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- BLIV
- ACRV Health Care
- Exchange
- BLIV NYSE
- ACRV Nasdaq
- Market Cap
- BLIV 39.8M
- ACRV 36.1M
- IPO Year
- BLIV 2025
- ACRV 2022
- Fundamental
- Price
- BLIV $4.33
- ACRV $1.05
- Analyst Decision
- BLIV
- ACRV Buy
- Analyst Count
- BLIV 0
- ACRV 7
- Target Price
- BLIV N/A
- ACRV $17.60
- AVG Volume (30 Days)
- BLIV 154.8K
- ACRV 728.6K
- Earning Date
- BLIV 01-01-0001
- ACRV 05-14-2025
- Dividend Yield
- BLIV N/A
- ACRV N/A
- EPS Growth
- BLIV N/A
- ACRV N/A
- EPS
- BLIV N/A
- ACRV N/A
- Revenue
- BLIV $1,355,200.00
- ACRV N/A
- Revenue This Year
- BLIV N/A
- ACRV N/A
- Revenue Next Year
- BLIV N/A
- ACRV N/A
- P/E Ratio
- BLIV N/A
- ACRV N/A
- Revenue Growth
- BLIV N/A
- ACRV N/A
- 52 Week Low
- BLIV $2.69
- ACRV $1.05
- 52 Week High
- BLIV $6.40
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- BLIV N/A
- ACRV 31.03
- Support Level
- BLIV N/A
- ACRV $1.06
- Resistance Level
- BLIV N/A
- ACRV $1.19
- Average True Range (ATR)
- BLIV 0.00
- ACRV 0.09
- MACD
- BLIV 0.00
- ACRV 0.05
- Stochastic Oscillator
- BLIV 0.00
- ACRV 0.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.